BCL6 and metabolic dysfunction-associated steatohepatitis: Interestingly, the Bcl6-LKO mice fed with CDAHFD exhibited physiological levels of total and HDL cholesterol, which suggest that Bcl6 regulates the liver cholesterol metabolic pathways during NASH progression.